Search · resolved
Which podcasts are discussing BMY?
5 ATTRIBUTED IDEAS · 5 EPISODES · 3 SHOWS
The shows
CNBC Fast Money
Motley Fool Money
Barron's Streetwise
Where the discussion went deepest
3 AUG1W AGOMOTLEY FOOL MONEY · 2:30
23 JUL3W AGOCNBC FAST MONEY · 07:30
Capital rotates into large-cap pharma and biotechs
“The panel presented large-cap pharmaceutical and biotech stocks as primary beneficiaries of rotation out of volatile tech and AI names.”
Intel Earnings Beat…And Yields Spike Ahead of Fed Meeting 7/23/26
In depth · 4/5Verify in source →
30 JUN30 JUNCNBC FAST MONEY · 03:40
AI drug discovery tools boost pharma efficiency
“Anthropic's new Claude Science platform was framed as an AI tool to accelerate drug discovery and improve R&D efficiency for major pharmaceutical companies.”
The Best First Half Ever for Semis… And Nike Report Results 6/30/26
In depth · 4/5Verify in source →
8 JUN8 JUNMOTLEY FOOL MONEY · 10:35
Bristol-Myers' growth portfolio eclipses legacy loss
“The argument presented is that Bristol-Myers Squibb is reaching an operational turning point where revenue from its new growth portfolio is outpacing generic revenue erosion from patent cliffs.”
Another Semiconductor Stock Is Headed to the S&P 500 · with Marvell Technology
In depth · 4/5Verify in source →
19 DEC19 DEC 2025BARRON'S STREETWISE · 9:30
Bristol-Myers' cheap valuation with dividend
“The bull case for Bristol-Myers Squibb: its status as a 'have-not' in the drug industry has created a cheap valuation with a high, sustainable dividend and an underappreciated pipeline.”
Andrew Bary’s Top Stocks for 2026
Substantive discussion · 3/5Verify in source →
The weekly signal
Get a weekly digest of what podcasts said about your watchlist.
Pick a few tickers. Once a week we send the most-discussed ideas across finance podcasts, attributed and linked so you can verify. No noise, no advice.
Double opt-in: we’ll email you to confirm before anything else. We store your email and chosen tickers only to send this digest. Nothing else, and we never share them.